A Study of the Effectiveness of Armodafinil to Treat Cancer-Related Fatigue in Patients With Multiple Myeloma
Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of armodafinil for the treatment of
cancer-related fatigue in adult patients with multiple myeloma. The study consists of a
screening period, followed by a 56-day treatment phase, and a final assessment to occur 28
days after the end of the last treatment.